|
| |
PAH
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 18184144 |
The birth prevalence of PKU in populations of European, South Asian, and sub-Saharn African ancestry living in South East England is reported. |
| 11678552 |
Observational study of genetic testing. (HuGE Navigator) |
| 11172645 |
Observational study of genotype prevalence. (HuGE Navigator) |
| 11385716 |
Observational study of genetic testing. (HuGE Navigator) |
| 12173030 |
Observational study of genotype prevalence. (HuGE Navigator) |
| 12200907 |
Observational study of gene-disease association. (HuGE Navigator) |
| 12640344 |
Observational study of gene-disease association. (HuGE Navigator) |
| 12649065 |
Observational study of genetic testing. (HuGE Navigator) |
| 12777691 |
Observational study of genetic testing. (HuGE Navigator) |
| 14654659 |
Observational study of gene-disease association. (HuGE Navigator) | →View more information from publications. |
Recent Publications on PAH: |  |
Degradation of phenanthrene by the endophytic fungus Ceratobasidum stevensii found in Bischofia polycarpa.
Some strains of white rot fungi, non-lignolytic fungi and... | 3rd November, 2009
| Jiangsu key Laboratory for Biodiversity and Biotechnology, Life Science
| Biodegradation. 2009 Nov 1.
DOI Direct Link |
Tadalafil, a Long-Acting Inhibitor of PDE5, Improves Pulmonary Hemodynamics and Survival Rate of Monocrotaline-Induced Pulmonary Artery Hypertension in Rats.
The aim of this study was to assess the effect of tadalafil (0.5, 2.5, and... | 3rd November, 2009
| Lilly Research Laboratories Japan, Eli Lilly Japan K.K., Japan.
| J Pharmacol Sci. 2009 Oct 31.
|
T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.
RATIONALE: Mounting data suggest that immune cell abnormalities... | 3rd November, 2009
| Department of Pediatrics, Division of Pulmonary, Allergy, and Immunology
| Respir Med. 2009 Oct 30.
DOI Direct Link |
Importance of CYP1A1 and CYP1B1 in bioactivation of benzo[a]pyrene in human lung cell lines.
Polycyclic aromatic hydrocarbons are ubiquitous environmental pollutants... | 3rd November, 2009
| Section for Toxicology, Department of Chemical and Biological Working
| Toxicol Lett. 2009 Oct 29.
DOI Direct Link |
Differential effects of nitro-PAHs and amino-PAHs on cytokine and chemokine responses in human bronchial epithelial BEAS-2B cells.
Nitro-polycyclic aromatic hydrocarbons (nitro-PAHs) are found in diesel... | 3rd November, 2009
| Department of Air Pollution and Noise, Division of Environmental Medicine,
| Toxicol Appl Pharmacol. 2009 Oct 28.
DOI Direct Link |
→View more research publications. |
Press Releases on PAH:
|
 |
| Merck Serono Launches New Website on Phenylketonuria |
25th November, 2009 |
|
GENEVA, November 25 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced
today the launch of a website dedicated to phenylketonuria (PKU), a rare
inborn metabolic
|
| United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food |
5th November, 2009 |
BioMarin Pharmaceutical Inc. |
NOVATO, Calif., Nov. 5 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has issued a patent covering
|
| Dong-A PharmTech Co., Ltd. Announces Start of Phase III Trials for Udenafil, Its New Erectile Dysfunction Drug Under Development |
4th November, 2009 |
Dong-A PharmTech Co. Ltd. |
SEOUL, Korea, Nov. 4 /PRNewswire/ -- Dong-A PharmTech Co. Ltd., announced that its U.S. partner, Warner Chilcott plc, has initiated two, phase III trials for udenafil, a new long acting
|
| Study Finds Life-Threatening Risks from Medication Errors in Hospitals Treating Pulmonary Hypertension Patients |
4th November, 2009 |
Medco Health Solutions, Inc. |
SAN DIEGO, Nov. 4 /PRNewswire-FirstCall/ -- Pulmonary arterial hypertension (PAH) patients using infused drugs have suffered serious injury or in some cases died from medication errors in
|
| United Therapeutics Corporation Reports Third Quarter 2009 Financial Results |
29th October, 2009 |
United Therapeutics Corporation |
SILVER SPRING, Md., Oct. 29 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended September 30,
|
PAH results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for PAH,
or search for PAH on BioPortfolio's antibody search engine.
This page has been viewed 138 times
Recent Search Terms used to find this page: Ambrisentan hplc | phenylalanine hydroxylase supplier | pah antibody | ambrisentan HPLC purity | india pku prevalence | Phenylalanine hydroxylase supplier | ambrisentan hplc | ambrisentan HPLC | ambrisentan hplc | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
